A fundamental analysis of Alkyl Amines Chemicals Limited (ALKYLAMINE) covering revenue trends, profitability, valuation, and shareholding patterns.
Alkyl Amines Revenue Trend
The top line slipped 2.1% to ₹1,568 Cr in FY2026, as Alkyl Amines Chemicals Limited failed to hold on to its prior revenue levels.
Over a 10-year span, Alkyl Amines Chemicals Limited grew revenue from ₹484 Cr to ₹1,568 Cr, compounding at 12.5% annually — a rate most peers in the specialty chemicals space would find difficult to match.
With a top line of ₹1,568 Cr, Alkyl Amines Chemicals Limited sits comfortably in the mid-sized tier of Indian chemicals companies by revenue.
| Year | Revenue | YoY % |
|---|---|---|
| FY2026 | ₹1,568 Cr | -2.1% |
| FY2025 | ₹1,602 Cr | +10.0% |
| FY2024 | ₹1,456 Cr | -14.2% |
| FY2023 | ₹1,696 Cr | +8.9% |
| FY2022 | ₹1,557 Cr | — |
View Alkyl Amines Chemicals Limited's full 10-year revenue trend with CAGR analysis →
Alkyl Amines Profitability
Profitability retreated in FY2026 for Alkyl Amines Chemicals Limited, with net income declining 3.3% to ₹180 Cr.
Margins were broadly flat on the year, with net profit margin holding at roughly 11.5% in FY2026.
Diluted EPS for FY2026 came in at ₹35.15, stepping back from ₹36.25 in the prior year.
Is Alkyl Amines Undervalued
Under the P/E Ratio model, Alkyl Amines Chemicals Limited carries an estimated intrinsic value of ₹2,045 (13.4% upside).
At present, Alkyl Amines Chemicals Limited shares are trading at ₹1,802.90.
Craytheon calculates intrinsic value through two additional lenses: the EPS Growth model and the DCF model. The full breakdown with assumptions is in the detailed analysis.
| Model | Est. Fair Value | vs. Current Price |
|---|---|---|
| P/E Ratio | ₹2,045 | 13.4% upside to fair value |
| EPS Growth | Upgrade | Upgrade |
| DCF | Upgrade | Upgrade |
See all valuation models for Alkyl Amines Chemicals Limited with detailed assumptions →
Alkyl Amines Shareholding Pattern
Promoter ownership has been steady at 72.0%, unchanged across the last 4 quarters.
Foreign institutional investors held 3.5% as of March 2026, edging up from 3.2%.
Domestic institutional investors held 3.0% as of March 2026, up from 2.6% in the prior period.
| Quarter | Promoter | FII | DII | Public |
|---|---|---|---|---|
| Mar 2026 | 72.0% | 3.5% | 3.0% | 21.5% |
| Dec 2025 | 72.0% | 3.5% | 3.0% | 21.5% |
| Sep 2025 | 72.0% | 3.4% | 2.9% | 21.7% |
| Jun 2025 | 72.0% | 3.2% | 2.6% | 22.1% |
Track quarterly shareholding changes for Alkyl Amines Chemicals Limited →
Alkyl Amines Balance Sheet
Proportional view as of 23 Jun 2026. Hover blocks for details.
Assets
Liabilities & Equity
In FY2026, the total asset base came in at ₹18.95B, up 6.0% YoY from ₹17.89B.
Property, Plant & Equipment accounts for 58.8% of the total, ahead of Other Assets (14.8%) and Receivables (12.2%).
Capital structure: 80.9% equity, 0.1% debt, 19.0% operating liabilities. Over the year, debt is down 78.5% and equity is up 9.3%.
Balance sheet composition — FY 2026
| Category | Value |
|---|---|
| Cash & ST Investments | 1.45B |
| Receivables | 2.30B |
| Inventories | 1.22B |
| Property, Plant & Equipment | 11.15B |
| Intangibles & Goodwill | 29.07M |
| Other Assets | 2.80B |
| Category | Value |
|---|---|
| Equity | 15.33B |
| Short-term Debt | 7.97M |
| Long-term Debt | 3.91M |
| Trade Payables | 1.51B |
| Other Liabilities | 2.10B |
Alkyl Amines Investment Snapshot
Taken together, here is what the numbers say about Alkyl Amines Chemicals Limited (ALKYLAMINE) as it heads into the next fiscal year.
Revenue stood at ₹1,568 Cr in FY2026, 2.1% below the prior year.
The long-run compounding rate sits at 12.5% annually, measured over 10 years.
The business remains profitable, with net income of ₹180 Cr and a net margin of 11.5%.
The P/E Ratio model implies 13.4% upside to fair value from the current price. The remaining two models are worth cross-checking before drawing a conclusion — sign up to see the full analysis.
Unlock Full Analysis
Want to dig deeper? Craytheon's platform provides 10 years of financial data, three valuation models, and insider trading activity for Alkyl Amines Chemicals Limited.